Цитосар 500 мг инъекция

What is Cytosar 500 mg Injection?
Cytosar 500 mg Injection is a potent chemotherapy medication used in the treatment of various types of cancer. Its active ingredient is Cytarabine, a cytotoxic antimetabolite that interferes with DNA synthesis, thereby inhibiting the growth and proliferation of cancer cells.

How it Works:
Cytarabine is a pyrimidine analog that gets incorporated into DNA and RNA, disrupting nucleic acid synthesis. This action is particularly effective against rapidly dividing cells, such as cancer cells, leading to their death. It is primarily used in the treatment of acute myeloid leukemia (AML) and certain types of lymphoma.

Indications:
Cytosar 500 mg Injection is indicated for the induction and consolidation of remission in acute myeloid leukemia (AML) in adults and children. It may also be used in combination with other chemotherapy agents for the treatment of other hematologic malignancies.

Dosage and Administration:
The dosage and administration of Cytosar 500 mg Injection are determined by a qualified healthcare professional based on the specific type and stage of cancer, as well as the patient’s overall health. It is typically administered intravenously or subcutaneously. Strict adherence to the prescribed regimen is crucial for optimal therapeutic outcomes.

Side Effects:
Common side effects associated with Cytosar 500 mg Injection include bone marrow suppression (leading to decreased white blood cells, red blood cells, and platelets), nausea, vomiting, diarrhea, hair loss, and mucositis. More serious side effects can occur, and patients should report any unusual symptoms to their doctor immediately.

Storage:
Cytosar 500 mg Injection should be stored at room temperature (20°C to 25°C or 68°F to 77°F) and protected from light. It should not be frozen. After reconstitution, the solution should be used promptly or stored under refrigeration.